TheScreener - Koninklijke DSM N.V. (DSM) DSM KONINKLIJKE reduced its risk exposure resulting in an upgrade to Slightly Positive

Report

TheScreener

EUR 12.95 For Business Accounts Only

DSM KONINKLIJKE reduced its risk exposure resulting in an upgrade to Slightly Positive

DSM KONINKLIJKE (NL), a company active in the Speciality Chemicals industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 2 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date November 19, 2021, the closing price was EUR 198.40 and its potential was estimated at EUR 208.32.

20/11/2021 6 EN

Underlying

Koninklijke DSM N.V.

Royal DSM is engaged in the creation of products and services in Life Sciences and Materials Sciences. Co.'s products and services are used globally in range of markets and applications in healthcare, pharmaceutical automotive and chemicals sectors. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. The activities of Co. are grouped into four clusters: Nutrition, Pharma, Performance Materials and Polymer Intermediates.

See profile

NL0000009827 Netherlands

Provider

TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.

See profile

Other Reports on these Companies

ING Financial Markets

Benelux Morning Notes

Aalberts: Preview; facing realistic expectations. BAM: Hard hats off! dsm-firmenich AG: Animal Farm(ed out). Econocom: Sales and net profit in line, REBITA margin better, net debt above. Fagron: 2H23 REBITDA beats 2%, driven by US Compounding, marred by sharp EMEA margin drop. Results Calendar

February 15, 2024 February 15, 2024 1 EN

ING Financial Markets

DSM-Firmenich/Vitamin overdose/BUY

We update our forecasts and valuation for dsm-firmenich. Incorporating the impact of restructuring, the vitamin business lowers our 2024F adjusted EBITDA by 23% to €1.9bn. Applying peer Givaudan's Bloomberg consensus 2024F EV/EBITDA multiple to DSM-Firmenich gives us a 12-month fair value of €158 (down from €182). We adjust our target price accordingly and maintain our BUY recommendation.

December 22, 2023 December 22, 2023 1 EN

ING Financial Markets

Benelux Morning Notes

Aalberts: Preview - slowing top line growth. AB InBev: Steady hand. Aedifica: 2023 EPS guidance slightly up, DPS reconfirmed. DSM-Firmenich AG: Vitamin overdose. Mithra Pharmaceuticals: Appointment of new independent directors required. Randstad: Strategic update at capital markets day

October 31, 2023 October 31, 2023 1 EN

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

AC ENERGY CORP (PH), a company active in the Alternative Electricity industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 4 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date April 8, 2022, the closing price was PHP 8.54 and its expected value was estimated at PHP 8.53.

Free Trial

April 9, 2022 April 9, 2022 1 EN

With a more favourable environment, VUKILE PROPERTY improves to Positive

VUKILE PROPERTY (ZA), a company active in the Real Estate Holding & Development industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date April 5, 2022, the closing price was ZAR 13.72 and its potential was estimated at ZAR 15.16.

Free Trial

April 6, 2022 April 6, 2022 1 EN

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

The independent financial analyst theScreener just requalified the general evaluation of ROYAL BAFOKENG PLATINUM (ZA), active in the Platinum & Precious Metals industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date April 5, 2022, the closing price was ZAR 159.78 and its target price was estimated at ZAR 127.50.

Free Trial

April 6, 2022 April 6, 2022 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

DSM KONINKLIJKE reduced its risk exposure resulting in an upgrade to Slightly Positive

Empowering Investors

Benelux Morning Notes

DSM-Firmenich/Vitamin overdose/BUY

Benelux Morning Notes

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

With a more favourable environment, VUKILE PROPERTY improves to Positive

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe